KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

NovoCure (NVCR) Shares Issued (2016 - 2025)

NovoCure (NVCR) has disclosed Shares Issued for 12 consecutive years, with $77000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 348.39% to $77000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 584.4% year-over-year, with the annual reading at $6.1 million for FY2025, 183.53% up from the prior year.
  • Shares Issued hit $77000.0 in Q4 2025 for NovoCure, down from $2.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $18.8 million in Q4 2021 to a low of -$6.6 million in Q4 2023.
  • Historically, Shares Issued has averaged $2.2 million across 5 years, with a median of $2.1 million in 2025.
  • Biggest five-year swings in Shares Issued: tumbled 121.9% in 2022 and later soared 348.39% in 2025.
  • Year by year, Shares Issued stood at $18.8 million in 2021, then crashed by 121.9% to -$4.1 million in 2022, then crashed by 59.94% to -$6.6 million in 2023, then skyrocketed by 99.53% to -$31000.0 in 2024, then surged by 348.39% to $77000.0 in 2025.
  • Business Quant data shows Shares Issued for NVCR at $77000.0 in Q4 2025, $2.1 million in Q2 2025, and $5.2 million in Q1 2025.